SOLID FORMS OF N-(4-(7-AZABICYCLO[2,2,1]HEPTAN-7-YL)-2-(TRIFLUOROMETHYL)PHENYL)-4-OXO-5-(TRIFLUOROMETHYL)-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE Russian patent published in 2015 - IPC C07D401/12 C07D487/08 A61K31/4709 A61P11/00 

Abstract RU 2568608 C2

FIELD: chemistry.

SUBSTANCE: invention relates to organic chemistry, specifically to novel solid forms of N-(4-(7-azabicyclo[2,2,1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide (A-HCl forms, B forms, B-HCl forms). The invention also relates to pharmaceutical compositions based on A-HCl forms, or B forms, or B-HCl forms, or combinations thereof; a method of treating diseases caused by CFTR mutations; a method of modulating CFTR activity in a biological sample.

EFFECT: obtaining novel stable solid forms of N-(4-(7-azabicyclo[2,2,1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide, having biological activity.

32 cl, 24 dwg, 13 tbl, 8 ex

Similar patents RU2568608C2

Title Year Author Number
SOLID FORMS OF N-(7-AZABICYCLO[2,2,1]HEPTAN-7-YL-)-2-(TRIFLUOROMETHYL)PHENYL)-4-OXO-5-(TRIFLUOROMETHYL)-1,4-DIHYDROQUIINOLINE-3-CARBOXAMIDE 2009
  • Chzhan Behjli
  • Kravets Mariush
  • Botfild Martin
  • Grotenkhejs Peter D J.
  • Van Gur Fredrik
RU2518479C2
METHOD FOR OBTAINING MODULATORS OF CYSTIC FIBROUSIS TRANSMEMBRANE CONDUCTANCE REGULATOR 2010
  • Ambkhaikar Narendra Bkhalchandra
  • Kh'Juz Robert
  • Kharli Dennis Dzhejms
  • Li Ehlejn Chungmin
  • Littler Bendzhamin
  • Numa Mekhdi
  • Reper Shtefani
  • Shet Urvi
RU2553989C2
3-CARBOXAMIDE-4-OXOQUINOLINE DERIVATIVES, USEFUL AS MODULATORS OF REGULATOR OF TRANSMEMBRANE CYSTIC FIBROSIS CONDUCTIVITY 2010
  • Jang Sjaotsin
  • Adida Rua Sara S.
  • Grotenkhejs Peter D. J.
  • Van Gor Fredrik F
  • Botfild Martin K.
  • Zlokarnik Gregor
RU2518897C2
CO-CRYSTALS OF TRANSMEMBRANE CONDUCTION REGULATOR MODULATORS IN CYSTIC FIBROSIS 2015
  • Strohmeier, Mark
  • Caesar, Jr., John P.
  • Connelly, Patrick Raymond
  • Fawaz, Majed
  • Luss-Lusis, Eduard
  • Mcclain, Brian R.
  • Medek, Ales
  • Miao, Hai
  • Nti-Addae, Kwame Wiredu
  • Yin, Ping
  • Zhang, Yuegang
RU2749213C2
SOLID FORMS OF 3-(2, 2-DIFLUOROBENZO[D][1,3] DIOXOL-5-YL)CYCLOPROPANCARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID 2011
  • Keskhavarz-Skhokri Ali
  • Chzhan Bejli
  • Kravets Mariush
RU2579370C2
METHOD OF OBTAINING MODULATORS OF CYSTIC FIBROUSIS TRANSMEMBRANE CONDUCTANCE REGULATOR 2010
  • Demattei Dzhon
  • Luker Adam R.
  • Neber-Lanzhill' Bobbianna
  • Trjudo Marten
  • Reper Shtefani
  • Rajan Majkl P.
  • Jap Darika Milfred Lao
  • Krjuger Brajan R.
  • Grotenkhejs Peter D. J.
  • Van Gur Frederik F.
  • Botfild Martin K.
  • Zlokarnik Gregor
RU2543714C2
SILICON-CONTAINING IVACAFTOR ANALOGUES 2017
  • Munoz, Benito
  • Parks, Daniel
  • Bastos, Cecilia, M.
RU2796112C2
PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES MEDIATED BY A TRANSMEMBRANE REGULATOR OF CYSTIC FIBROSIS (CFTR) 2013
  • Vervejs Marinus Yakobus
  • Karkare Radkhika
  • Mur Majkl Duglas
RU2692676C2
METHOD OF PRODUCING PHARMACEUTICAL COMPOSITIONS FOR TREATING CFTR MEDIATED DISEASES 2014
  • Swinney, Kelly, Ann
  • Hurter, Patricia, Nell
  • Nadig, David, E.
  • Smith, David
  • Thomas, Vance, Hayden
  • Warman, Martin, Paul
RU2718044C2
SOLID FORMS OF (R)-1-(2,2-DIFLUOROBENZO[d][1,3]DIOXOL-5-YL)-N-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL)CYCLOPROPANE CARBOXAMIDE 2011
  • Keskhavarz-Skhokri Ali
  • Chzhan Behjli
  • Alkasio Tim Ehdvard
  • Li Ehlejn Chungmin
  • Chzhan Juehgan
  • Kravets Mariush
RU2573830C2

RU 2 568 608 C2

Authors

Chzhan Behjli

Kravets Mariush

Luizi Brajan

Medek Ales

Dates

2015-11-20Published

2010-10-21Filed